Alterity Therapeutics (ATHE) Free Cash Flow (2010 - 2020)
Alterity Therapeutics (ATHE) recorded quarterly Free Cash Flow of -$6.2 million in Q2 2020, down 250.94% quarter-over-quarter from -$1.8 million in Q4 2019, and up 36.76% on a YoY basis from -$4.5 million in Q3 2019.
Alterity Therapeutics (ATHE) Free Cash Flow (2010 - 2020) Analysis & Trends
Alterity Therapeutics' Free Cash Flow history runs 7 years deep, the most recent figure standing at -$6.2 million for Q2 2020.
- In Q2 2020, Free Cash Flow rose 36.76% year-over-year to -$6.2 million; the TTM figure through Dec 2021 stood at -$6.2 million (up 65.11% YoY), while the FY2025 annual figure was -$7.3 million, up 11.76% from the prior year.
- Free Cash Flow was -$6.2 million for Q2 2020 at Alterity Therapeutics, down from -$1.8 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$47278.4 in Q2 2018 to a low of -$9.8 million in Q2 2019.
- Historically, Free Cash Flow has averaged -$3.8 million across 5 years, with a median of -$4.4 million in 2017.
- The sharpest annual moves came in 2018 and 2019: Free Cash Flow jumped 98.93% in 2018, then plunged 20575.33% in 2019.
- A 5-year view of Free Cash Flow shows it stood at -$449190.3 in 2016, then plunged by 100.19% to -$899256.0 in 2017, then tumbled by 475.87% to -$5.2 million in 2018, then surged by 65.99% to -$1.8 million in 2019, then plunged by 250.94% to -$6.2 million in 2020.
- The last three Free Cash Flow figures came in at -$6.2 million (Q2 2020), -$1.8 million (Q4 2019), and -$9.8 million (Q2 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 63,220.27 |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 848.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | -6.18 Mn |
| Jun 30, 2020 | -6.18 Mn |
| Dec 31, 2019 | -1.76 Mn |
| Dec 31, 2019 | -1.76 Mn |
| Jun 30, 2019 | -9.77 Mn |
| Jun 30, 2019 | -9.77 Mn |
| Dec 31, 2018 | -5.18 Mn |
| Dec 31, 2018 | -5.18 Mn |
| Jun 30, 2018 | -47,278.38 |
| Jun 30, 2018 | -47,278.38 |
| Dec 31, 2017 | -899,256.01 |
| Dec 31, 2017 | -899,256.01 |
| Jun 30, 2017 | -4.41 Mn |
| Jun 30, 2017 | -4.41 Mn |
| Dec 31, 2016 | -449,190.35 |
| Dec 31, 2016 | -449,190.35 |
| Jun 30, 2016 | -5.54 Mn |
| Jun 30, 2016 | -5.54 Mn |
| Jun 30, 2011 | -4,839.60 Bn |
| Jun 30, 2011 | -4,839.60 Bn |